U.S. Absent From Japan's New Center

Japan launched an R&D program in superconductivity this month without the international collaborators that officials there had hoped to attract. Some U.S. researchers said they didn’t know they had been invited, while others are waiting to see how the program develops. The International Superconductivity Technology Center (ISTEC) that opened January 14 is being funded by about 50 Japanese companies, including large electronics firms such as Toshiba and Hitachi, electric utility compani

Written byStephen Greene
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Japan launched an R&D program in superconductivity this month without the international collaborators that officials there had hoped to attract. Some U.S. researchers said they didn’t know they had been invited, while others are waiting to see how the program develops.

The International Superconductivity Technology Center (ISTEC) that opened January 14 is being funded by about 50 Japanese companies, including large electronics firms such as Toshiba and Hitachi, electric utility companies, major steel and materials corporations, and several banks. The effort is being coordinated by the Ministry of International Trade and Industry (MITT), which will support research at the non-profit foundation’s new laboratory in Tokyo.

To soften a perception that the effort is meant to achieve world dominance in superconductivity applications (see THE SCIENTIST July 13, p. 1), MITT has emphasized that foreign firms are welcome to join. But that message seems not. to have reached many U.S. scientists.

“It’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies